A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity - PubMed (original) (raw)
. 2006 Apr;69(4):1413-20.
doi: 10.1124/mol.105.021154. Epub 2006 Jan 11.
Affiliations
- PMID: 16407466
- DOI: 10.1124/mol.105.021154
A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity
Ryuichi Takezawa et al. Mol Pharmacol. 2006 Apr.
Abstract
3,5-Bis(trifluoromethyl)pyrazole derivative (BTP2) or N-[4-3, 5-bis(trifluromethyl)pyrazol-1-yl]-4-methyl-1,2,3-thiadiazole-5-carboxamide (YM-58483) is an immunosuppressive compound that potently inhibits both Ca2+ influx and interleukin-2 (IL-2) production in lymphocytes. We report here that BTP2 dosedependently enhances transient receptor potential melastatin 4 (TRPM4), a Ca2+-activated nonselective (CAN) cation channel that decreases Ca2+ influx by depolarizing lymphocytes. The effect of BTP2 on TRPM4 occurs at low nanomolar concentrations and is highly specific, because other ion channels in T lymphocytes are not significantly affected, and the major Ca2+ influx pathway in lymphocytes, ICRAC, is blocked only at 100-fold higher concentrations. The efficacy of BTP2 in blocking IL-2 production is reduced approximately 100-fold when preventing TRPM4-mediated membrane depolarization, suggesting that the BTP2-mediated facilitation of TRPM4 channels represents the major mechanism for its immunosuppressive effect. Our results demonstrate that TRPM4 channels represent a previously unrecognized key element in lymphocyte Ca2+ signaling and that their facilitation by BTP2 supports cell membrane depolarization, which reduces the driving force for Ca2+ entry and ultimately causes the potent suppression of cytokine release.
Similar articles
- Potent inhibition of store-operated Ca2+ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2.
Steinckwich N, Frippiat JP, Stasia MJ, Erard M, Boxio R, Tankosic C, Doignon I, Nüsse O. Steinckwich N, et al. J Leukoc Biol. 2007 Apr;81(4):1054-64. doi: 10.1189/jlb.0406248. Epub 2007 Jan 29. J Leukoc Biol. 2007. PMID: 17261548 - TRPM4 regulates calcium oscillations after T cell activation.
Launay P, Cheng H, Srivatsan S, Penner R, Fleig A, Kinet JP. Launay P, et al. Science. 2004 Nov 19;306(5700):1374-7. doi: 10.1126/science.1098845. Science. 2004. PMID: 15550671 - A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2.
He LP, Hewavitharana T, Soboloff J, Spassova MA, Gill DL. He LP, et al. J Biol Chem. 2005 Mar 25;280(12):10997-1006. doi: 10.1074/jbc.M411797200. Epub 2005 Jan 12. J Biol Chem. 2005. PMID: 15647288 - TRP channels in lymphocytes.
Schwarz EC, Wolfs MJ, Tonner S, Wenning AS, Quintana A, Griesemer D, Hoth M. Schwarz EC, et al. Handb Exp Pharmacol. 2007;(179):445-56. doi: 10.1007/978-3-540-34891-7_26. Handb Exp Pharmacol. 2007. PMID: 17217072 Review. - Insights into TRPM4 function, regulation and physiological role.
Vennekens R, Nilius B. Vennekens R, et al. Handb Exp Pharmacol. 2007;(179):269-85. doi: 10.1007/978-3-540-34891-7_16. Handb Exp Pharmacol. 2007. PMID: 17217063 Review.
Cited by
- ORAI1 Ca2+ Channel as a Therapeutic Target in Pathological Vascular Remodelling.
Shawer H, Norman K, Cheng CW, Foster R, Beech DJ, Bailey MA. Shawer H, et al. Front Cell Dev Biol. 2021 Apr 6;9:653812. doi: 10.3389/fcell.2021.653812. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33937254 Free PMC article. Review. - Calcium Permeable Channels in Cancer Hallmarks.
Tajada S, Villalobos C. Tajada S, et al. Front Pharmacol. 2020 Jul 7;11:968. doi: 10.3389/fphar.2020.00968. eCollection 2020. Front Pharmacol. 2020. PMID: 32733237 Free PMC article. Review. - Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.
Kaufmann U, Shaw PJ, Kozhaya L, Subramanian R, Gaida K, Unutmaz D, McBride HJ, Feske S. Kaufmann U, et al. J Immunol. 2016 Jan 15;196(2):573-85. doi: 10.4049/jimmunol.1501406. Epub 2015 Dec 16. J Immunol. 2016. PMID: 26673135 Free PMC article. - Blockage of Store-Operated Ca2+ Influx by Synta66 is Mediated by Direct Inhibition of the Ca2+ Selective Orai1 Pore.
Waldherr L, Tiffner A, Mishra D, Sallinger M, Schober R, Frischauf I, Schmidt T, Handl V, Sagmeister P, Köckinger M, Derler I, Üçal M, Bonhenry D, Patz S, Schindl R. Waldherr L, et al. Cancers (Basel). 2020 Oct 6;12(10):2876. doi: 10.3390/cancers12102876. Cancers (Basel). 2020. PMID: 33036292 Free PMC article. - Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
Sieber M, Baumgrass R. Sieber M, et al. Cell Commun Signal. 2009 Oct 27;7:25. doi: 10.1186/1478-811X-7-25. Cell Commun Signal. 2009. PMID: 19860902 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous